Haleon

HLN

Market cap $41.3B

Haleon PLC's (LSE:HLN, NYSE:HLN) management could be forgiven for feeling like pharmacists rearranging the medicine cabinet while the queue outside keeps growing. Barclays, in a detailed preview ahead of the company's third-quarter results, says the consumer health group's biggest headache remains its US inventory build-up, a problem Haleon is determined to “clean up” before year-end.

LONDON & SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide. Haleon has chosen Salesforce Life Sciences Cloud for Customer Engagement, Data Cloud, and Agentforce to support its 4,500-strong sales force globally. The AI-powered s.

Haleon PLC (LSE:HLN, NYSE:HLN) topped the FTSE 100 losers' list after Barclays downgraded the consumer health group from “overweight” to “equal weight” and lowered its price target from 430p to 380p.  The broker said the problem lies in Haleon's biggest market.

Help keep your kids smiling and sniffle-free this back-to-school season with a tasty new “popping” boost of immune-supporting vitamins and minerals. Help keep your kids smiling and sniffle-free this back-to-school season with a tasty new “popping” boost of immune-supporting vitamins and minerals.

Haleon plc (NYSE:HLN ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 2, 2025 11:15 AM EDT Company Participants Brian McNamara - CEO & Executive Director Conference Call Participants Warren Ackerman - Barclays Bank PLC, Research Division Presentation Warren Ackerman Head of European Consumer Equity Research Let's kickoff with the second session today. So welcome, everybody.

Barclays has repeated its 'overweight' call and 430p price target for Haleon PLC (LSE:HLN, NYSE:HLN) following a solid set of second-quarter results. In a note issued on Friday, it noted that the consumer health group continues to deliver organic revenue growth ahead of expectations.

Haleon plc (NYSE:HLN ) Q2 2025 Earnings Q&A Conference July 31, 2025 4:30 AM ET Company Participants Brian James McNamara - CEO & Executive Director Dawn Amanda Allen - CFO & Director Jo Russell - Head, IR Conference Call Participants Callum Elliott - Sanford C. Bernstein & Co., LLC.

Brian McNamara​​, chief executive of of Haleon said the company is "quite optimistic about emerging market growth," whilst still developing a "great" business in developed markets.

British consumer healthcare company Haleon lowered its annual organic revenue growth forecast to 3.5% on Thursday, citing weaker performance in the United States.

Investors interested in Medical - Products stocks are likely familiar with Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?